Drug Discovery

Lead Optimization

Bruker’s product suite delivers high quality, data-rich information to make the rational decisions in an efficient lead optimization process.

Información general

Once leads have been identified successfully, lead optimization starts to bring potent and safe drug candidates into the preclinical phase. Relevant aspects like affinity, selectivity, mode of action, synthesizability and ADMET-properties are typically improved in a multiple design-make-test-analyze (DMTA)-cycles. Bruker’s solutions provide fast, high-quality responses to ensure a high iterative pace in the DMTA-cycles required for the shortest possible time-to-market.

Picture provided by Maximilian Benz

A crucial element for any lead optimization project is the development of easily synthesizable compounds and analogs thereof. Novel synthetic technologies like microbatch synthesis allow to easily cover a broad chemical space by combinatorial synthesis but create the demand for the fast analysis of millions of compounds at volumes of a few nl only. Bruker’s rapifleX MPP  perfectly addresses this need and screens at highest pace to ensure rapid reaction control and surveillance of the chemical reactivity landscape. More detailed chemical information regarding structure, isomerization and reaction control based on larger volumes can easily be assessed by NMR , X-ray diffraction (XRD), and with the timsTOF Pro MS. Single-crystal X-ray diffraction (SC-XRD) (Link5) delivers a detailed picture of the 3D connectivity and arrangement of the atoms in the organic molecule.

A key element in lead optimization is to establish a structure-activity relationship in order to develop more potent ligands. X-ray methods, such as small angle X-ray scattering (SAXS) and single-crystal X-ray diffraction  deliver information on the structure of the protein-ligand complex, thus providing insights into spatial orientation of the ligand which is essential to rationally design more selective or potent ligands. Perfectly complementary for smaller proteins, NMR gives structural information about binding and dynamics in physiological conditions.  

Modern lead optimization requires details on temporal stability of a protein-analyte complex as early as possible. This information can be derived from the kinetic constants, like dissociation rate constants. Surface Plasmon Resonance (SPR) is highly suited at this stage as the real-time, label-free analysis of the kinetics offers direct insights beyond affinities or IC50. Moreover, the high flexibility of SPR Bruker systems allows to simultaneously investigate the binding of lead structures to up to 31 target proteins offering insights into specificity and selectivity.
Additionally, SPR allows to investigate the enthalpic and entropic contribution, key characteristics in lead optimization processes. The influence of co-factors and medium conditions such as tissue-specific pH on a protein-ligand interaction can further be analyzed by SPR.

Bruker’s mass spectrometry portfolio offers an additional layer of insight relevant during lead optimization. The timsTOF Pro makes use of the Parallel Accumulation Serial Fragmentation (PASEF) acquisition method, thus offering highly reliable, sensitive and fast insights into proteomics for in vitro mode of action studies. Furthermore, native MS-conditions allow to investigate protein-ligand complexes in orthogonal fashion, additionally providing information on stoichiometry besides affinities, selectivity and binding modes.

Eventually, lead optimization is also driven by improvements of ADMET-properties. Bruker’s SC-XRD, NMR, SPR and MS solutions are perfectly suited for the investigation all the way from binding assessment with plasma proteins (e.g. for increase of half-life) and metabolite analysis to distribution and toxicology studies. Most recently, our MALDI-imagining has turned out to be especially powerful studying the toxicology profile of compounds. Bruker’s magnetic resonance MS systems deliver a market-leading resolution of > 290’000 mass resolutions at m/z 400, thus enabling a comprehensive mapping of a compound.

Interesting lead compounds with optimized properties are likely to be tested in in vivo studies using both transgenic and disease models at the later stages of lead optimization. Conventionally, small rodents are used and often require ‘snap shot’ investigations where single time point experiments are carried out on excised tissue. However, Bruker’s preclinical imaging systems such as the BioSpec MRI and Skyscan micro CT can provide precise events during the disease that may be pertinent to the particular efficacy of the molecule. Bruker’s preclinical platform provides the ability to measure quantitatively and precisely anatomical, functional, metabolic and cellular mechanisms. The high data quality is ensured by longitudinal experiments where live results can influence the decision making much earlier compared to ex vivo tissue assessments. In addition, temporal in vivo biomarkers assessment within animal not only reduces total numbers of animals used but provides information on mechanisms in the intact fully functioning organ/tissue.  

Productos relacionados

Related Products



D8 VENTURE - el estándar de calidad y versatilidad en XRD de cristal único


La familia D8 DISCOVER es la plataforma de difractómetros de rayos X multipropósito definitiva que ofrece componentes tecnológicos líderes. Está diseñado para la caracterización estructural de toda la gama de materiales, desde polvos, materiales policristalices hasta películas delgadas epitaxiales de varias capas.
Avance 400 Nanobay

Instrumentos NMR

La RMN es una técnica analítica rica en información y no destructiva. Proporciona información detallada sobre la estructura molecular, los procesos dinámicos y permite la observación directa de las reacciones químicas.
rapifleX MALDI PharmaPulse

rapifleX® MALDI PharmaPulse®

The rapifleX® MALDI PharmaPulse® (MPP) enhances label-free HTS combining the unambiguousness of mass spectrometry with the required speed to comb through large compound libraries of millions of substances.
timsTOF Pro

timsTOF Pro

The new standard for 4D-Proteomics™ delivers revolutionary improvements in scan speed, with enhanced specificity and high sensitivity, using TIMS powered by PASEF® technology.


scimaX is powered by 2xR MRMS technology, bringing the "high hanging fruit" within easy reach.


El NANOSTAR con su incomparable modularidad es la herramienta ideal para la caracterización de nanoestructuras que van desde 1 nm a aproximadamente 125 nm, y superficies nanoestructuradas por SAXS, GISAXS y Nanography.
SPR-32 Pro

Sierra SPR®-32 Pro

From initial screening to detailed kinetic characterization and thermodynamics measurements, Sierra SPR®-32 Pro enables high-throughput SPR analysis of molecular interactions.
Fourier 80

Fourier 80

Basándose en décadas de experiencia en la creación de instrumentos de RMN de alta calidad, Bruker ha reinventado la espectroscopia de RMN de alto rendimiento en una forma compacta y rentable

BioSpec 3T

En un campo traslacional de 3 Tesla, el BioSpec 3T amplía la gama de sistemas multipropósito, preclínicos de RMN y MRS en una huella compacta y fácil de ubicar.


MicroCT de sobremesa de alta resolución con aislamiento de vibración, detector CCD y etapa de muestra de microposicionamiento.
Micro-CT para ciencias de la vida

Micro-CT para ciencias de la vida

La tomografía microcóctil es la imagen de rayos X en 3D, por el mismo método utilizado en las tomografías computarizadas de hospitales, pero a pequeña escala con una resolución masivamente mayor. Realmente representa la microscopía 3D, donde la estructura interna de los objetos a escala muy fina se identifica de forma no destructiva.




Service & Life Cycle Support for Magnetic Resonance and Preclinical Imaging

Bruker’s commitment to provide customers with unparalleled help throughout the buying cycle, from initial inquiry to evaluation, installation, and the lifetime of the instrument is now characterized by the LabScape service concept.

LabScape Maintenance Agreements, On-Site On-Demand and Enhance Your Lab are designed to offer a new approach to maintenance and service for the modern laboratory